REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laboratorio Farmaceutico Liphycos S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Laboratorio Farmaceutico Liphycos S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio Farmaceutico Liphycos S.A. is based in Ecuador. The head office is in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on June 10, 2014. The total number of employees is currently 4 (2023). In 2023, the company reported a net sales revenue drop of 40.59%. A growth of 8.82% was recorded in its total assets.

Headquarters
Anonas N54-15
Quito; Pichincha;

Contact Details: Purchase the Laboratorio Farmaceutico Liphycos S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Farmaceutico Liphycos S.A. report to view the information.
Outstanding Shares:
Purchase the Laboratorio Farmaceutico Liphycos S.A. report to view the information.
Registered Capital:
Purchase the Laboratorio Farmaceutico Liphycos S.A. report to view the information.
Incorporation Date:
June 10, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Laboratorio Farmaceutico Liphycos S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-40.59%▼
Total operating revenue
-40.59%▼
Operating profit (EBIT)
-48.12%▼
EBITDA
-75.29%▼
Net Profit (Loss) for the Period
N/A
Total assets
8.82%▲
Total equity
-7.94%▼
Operating Profit Margin (ROS)
-57.19%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-402.45%▼
Quick Ratio
-6.78%▼
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo